COVID-19 Updates
    
    
  
  News from the FDA/CDC
New challenge for docs: End of COVID federal public health emergency
The Biden administration intends to end by May 11 certain COVID-19 emergency measures used to aid in the response to the pandemic.
News from the FDA/CDC
New report says suicide rates rising among young Black people
Significant increases in suicide occurred among Native American, Black and Hispanic people.
Latest News
Risk of infections low among kids receiving systemic meds for psoriasis, study finds
The analysis included 2,338 patients with psoriasis aged 17 years and younger who started new treatment with ustekinumab, etanercept, or...
Commentary
Must-read acute care medicine articles from 2022
“When 2022 began, we started seeing some light at the end of the COVID-19 tunnel.”
Latest News
AAP approves 2023 child and adolescent immunization schedule
The updated recommendations do not include major changes from those released in 2022 by the Advisory Committee on Immunization Practices, except...
Commentary
A new (old) drug joins the COVID fray, and guess what? It works
Part of the reason the monoclonals have failed lately is because of their specificity.
From the Journals
Maternal COVID-19 vaccine curbs infant infection
Maternal mRNA COVID-19 vaccination during pregnancy was less effective in protecting infants against omicron.
From the Journals
Acute cardiac events common during COVID hospitalization
“We expected to see acute cardiac events occurring among adults hospitalized with COVID-19 but were surprised by how frequently they occurred.”
Feature
More data back Guillain-Barré risk with Janssen COVID shot
Observed GBS cases after the Janssen shot were 2 to 3 times greater than expected, based on background rates within 21 and 42 days of vaccination...
Feature
Inflammation and immunity troubles top long-COVID suspect list
“I think that it’s a much more complex picture than just inflammation, or just autoimmunity, or just immune dysregulation,” says expert.
Feature
COVID emergency orders ending: What’s next?
There will be cost-sharing changes for COVID-19 vaccines, testing, and certain treatments.